Biotech

All Articles

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.OS Therapies will list on the NYSE American inventory swap this morning through a $6.4 million IPO ...

ALX's waning CD47 action fee sends out sell spiraling down

.ALX Oncology's stage 2 stomach cancer action price has actually diminished. After viewing its own C...

Ionis centers eye condition coming from aim ats of Roche-partnered possibility after records let down

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed assumptio...

Biogen's CEO claimed no high-risk handle 2023. He prepares to become daring

.While Biogen's pharma peers are actually looking for late-stage properties along with little bit of...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech trying to find a pipe after it junked its own lead pos...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually restored civil liberties to a very early Alzheimer's condition system to Denali...

Takeda faucets new head people oncology organization-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings a...

Vertex, beaten by AATD again, falls 2 possessions on throw away heap

.Vertex's effort to manage a rare genetic disease has reached another problem. The biotech tossed tw...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits document wasn't short of big information. The company invited ...

Galapagos pauses CAR-T cell therapy hearing over Parkinsonism case

.Galapagos has stopped briefly registration in a trial of a BCMA-directed CAR-T tissue therapy, push...